Scientists at the University of Miami's Diabetes Research Institute are studying transplanted islet cells in patients with severe type 1 diabetes. Those who have undergone the treatment have been able to stay off insulin for five years, which is comparable to patients who received pancreas transplants. Researchers are working on ways, such as encapsulation, to make the transplanted cells survive longer and minimize the use of antirejection drugs.
Islet cell transplants show promise for treating type 1 diabetes
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||